Lower Extremity Revascularization in Elderly Found Lacking

This article originally appeared here.
Share this content:
Lower Extremity Revascularization in Elderly Found Lacking
Lower Extremity Revascularization in Elderly Found Lacking

(HealthDay News) -- Lower extremity revascularization in frail nursing home residents rarely improves their ambulatory status, according to a study published online April 6 in JAMA Internal Medicine.

Emily Finlayson, M.D., director of the University of California San Francisco Center for Surgery in Older Adults, and colleagues conducted a review of Medicare claims data which revealed that 10,784 long-term nursing home residents had undergone the procedure between 2005 and 2009. Their average age was 82, and many were in very poor health. Three out of four could not walk, and 40 percent had experienced a decline in their overall physical function. In addition, 60 percent had cognitive impairment, 57 percent had congestive heart failure, and 29 percent had renal failure.

A year after surgery, half of the patients had died. Among 7,188 patients unable to walk prior to surgery, 89 percent either died or remained nonambulatory. Of 1,672 nursing home residents who could walk beforehand, 63 percent had died or lost the ability to walk within a year.

"Many patients do not ever get back to their baseline function, regardless of what kind of procedure they have," Finlayson told HealthDay. The cost varies across the nation, but these patients tend to have high complication rates that drive up the total cost of care, Finlayson added. However, Finlayson said her findings should not be used to declare the surgery wasteful and useless. She likened the procedure to repairing a broken hip. "We know if it's not fixed, it causes excruciating pain and increasing disability. The goals of surgery are sometimes to prolong life, but sometimes they're to ease symptoms and ease suffering," she explained.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »